A logo sign outside of the headquarters of UnitedHealthcare in Minnetonka, Minn., on Oct. 25, 2015. By Meagan Flynn Meagan Flynn Morning Mix reporter Email Bio Follow May 1 at 6:27 AM Richard Cole has had a hard time finding a judge to hear his case, if only because they all keep recusing themselves.
In Scola’s own case, the judge said “top medical experts across the country” recommended the proton beam radiation therapy to him when he was diagnosed with prostate cancer in 2017, although he ultimately opted to have surgery. At that point, the cancer had already spread to his lymph nodes, meaning surgery wouldn’t be enough to stop it, he said. He consulted with doctors nationwide about what to do next, including the CEO and executive medical director at the Miami Cancer Institute. The consensus was decisive, he said: Proton beam radiation therapy was both less invasive and more effective, Cole said.
To go forward, he had to pay $85,000 out of pocket for the treatment — which he said he recognizes would likely not be a possibility for many people.
Now, as to the actual issue UHC is disgusting. They are working hard daily to make sure we move to single payer system. Ignoring the facts and denying people an approved treatment further injures people.
really should not post articles that almost no one can read. I found the article elsewhere. Your methods increase the ignorance of the populace and encourage fake free news daily.
Thank you, Republicans.
Father-in-Law in same situation. Denied proton therapy and even denied a PET to stage the cancer.
It’s what UHC does.
No cancer patient should be denied it’s so much other things on the table to worry about!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck's Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study resultsMerck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of the drugmaker were down 0.05% in premarket trade. An earlier Phase 3 study looking at Keytruda as a second-line treatment for gastric cancer also failed to show a survival benefit, though the Food and Drug Administration did approve the drug in 2017 as a third-line treatment for patients with advanced gastric cancer. Keytruda is currently used for many other cancer indications, including treating certain subsets of patients with melanoma, lung cancer, Hodgkin lymphoma and cervical cancer, among many others. Shares of the pharmaceutical giant have fallen 0.1% in the year to date, while the S&P 500 has gained 16.7%.
Source: MarketWatch - 🏆 3. / 97 Read more »
Woman lied about having kidney cancer to steal fundraising money, police sayHannah Hume is accused of felony attempt to obtain property by false pretense after allegedly lying about kidney cancer. Not the First time... Unfortunately won't be the Last time... Really disgusting. Not only that, it will make some people, if not all, not wanting to donate $$ to someone who really has severe illness because of that thief. Registered Democrat for sure...
Source: Newsweek - 🏆 468. / 52 Read more »
Medicare proposes higher payments for innovative cancer treatmentIf approved, the increased reimbursements for CAR T-cell therapy and “breakthrough” devices would go into effect on Oct. 1. Good day. It would be ideal that this magnificent newspaper make the Spanish version of such good articles as this one. Thank you!
Source: washingtonpost - 🏆 95. / 72 Read more »
Screening for lung cancer is a controversial ideaAmerica's National Lung Screening Trial found that the smokers scanned for lung cancer over 4 years led to a 7% fall in mortality alllibertynews Is this study in the US? When would you anticipate it might happen here?
Source: TheEconomist - 🏆 6. / 92 Read more »
Scientists with ties to China ousted from US cancer center amid fears of foreign influenceA leading cancer research center in Texas took action against a handful of faculty members for sharing confidential information and failing to disclose foreign ties, it says. When realDonaldTrump made excuses for Saudi Prince Bin Salman for ordering capture, torture, dismemberment of a US based journalist Khashoggi, he gave a green light for more crimes against humanity...Now this..American leadership at peril: VOTE MIGHTY FUNNY DON JR WAS TAKING MONEY FROM HIS ORGANIZATION FROM CANCER PATIENTS NO 1 DARE TALK ABOUT THAT COULD THIS TIE IN Odd how we hold elected officials to a different standard for the same offenses.
Source: CNN - 🏆 4. / 95 Read more »
Eli Lilly to Pull Cancer Drug From Market After Failed StudyEli Lilly plans to withdraw its cancer drug Lartruvo from the market after a study showed that it failed to prolong overall survival in a clinical trial.
Source: WSJ - 🏆 98. / 63 Read more »
Baltimore Ravens ask blind, 13-year-old, superfan battling cancer to announce draft pickThe lead-up to the NFL Draft is incredibly exciting for hundreds of players hoping for life-changing news and millions of fans praying that their team will snag the next Tom Brady or Julio Jones, but it's hard to imagine anyone looking forward to it more than 13-year-old Mo Gaba. Hope nobody trades up ahead of the ravens and selects this kid before his favorite team can. Whoever picks him, hopefully he gets a big signing bonus! That explains why he's a Ravens fan. That's how behind the times the NFL is.....braille is still a great new concept to them.
Source: CNN - 🏆 4. / 95 Read more »
He Conquered Cancer, Then 15 Spartan Races in a YearCompleting one muddy obstacle-course Trifecta at full strength is hard enough, but this 77-year-old wanted to knock out five. Not wasting any time. Good for him. You think you are better than me old man? Yes
Source: WSJ - 🏆 98. / 63 Read more »
A Silicon Valley start-up is making cancer treatment for dogs more preciseSilicon Valley start-up One Health says it's too soon to publish data, but says many of its canine clients are living longer than would be expected using traditional treatment.
Source: CNBC - 🏆 12. / 72 Read more »
Arlene Sharpe's Science Helps Cancer Patients, And 'It Doesn't Get Better Than That'The chair of Harvard's new immunology department helped pioneer the science behind the most promising new type of cancer treatment in decades –– and it all began with lima beans in the living room. WBUR WBUR Fantastic
Source: NPR - 🏆 96. / 63 Read more »
AstraZeneca: EU advises wider use for cancer drugAstraZeneca PLC (AZN.LN) said Monday that Europe's medicines regulator has recommended that the indication for the company's cancer drug Lynparza be expanded. The European Medicines Agency's Committee for Medicinal Products for Human Use has given the go-ahead for the use of Lynparza as a first-line maintenance treatment of advanced ovarian cancer with a mutation in the BRCA gene. Who cares about the dictatorship that is the EU. Each country can decide for themselves.
Source: MarketWatch - 🏆 3. / 97 Read more »